NYSE · OHIReal EstateREITs

Omega Healthcare Investors news

$46.54−0.30%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days2English, de-duplicated
Positive00% of coverage
Neutral2100%
Negative00% of coverage

About Omega Healthcare Investors

DRH or OHI: Which Is the Better Value Stock Right Now?
Zacks Investment ResearchSep 23, 11:40 AM ETNeutral

OHI has a weaker Zacks Rank (#3 Hold), higher valuation multiples (P/E of 14.32, P/B of 2.5), and a lower Value grade (C), positioning it as less attractive compared to DRH but not necessarily unfavorable on its own merits.

GLPI vs. OHI: Which Stock Is the Better Value Option?
Zacks Investment ResearchAug 27, 11:40 AM ETNeutral

OHI has a Zacks Rank #3 (Hold) with higher valuation multiples (forward P/E of 14.48, PEG of 1.83, P/B of 2.52) and a lower Value grade of C, suggesting it is less attractive as a value opportunity relative to GLPI.

Also mentions OHI

Articles that tag OHI but are mainly about other companies.

PACS Expands Florida Footprint With 32-Facility Acquisition
Zacks Investment ResearchSep 8, 11:40 AM ETNeutral

Omega is mentioned as the existing REIT landlord leasing the facilities to PACS. While this represents a transaction, the article provides no information about Omega's financial impact or strategic implications, warranting a neutral stance.

3 Healthcare Stocks Every Retiree Should Consider
The Motley FoolMay 8, 7:15 PM ET▲ Positive

Recommended as a senior housing REIT with an attractive 5.8% yield. The company has recovered from COVID-related challenges, maintained its dividend throughout the pandemic, and is positioned to benefit from long-term demographic trends of an aging population.

3 Healthcare Stocks Providing Relief for the Sandwich Generation
Investing.comApr 10, 10:50 AM ET▲ Positive

REIT with stable, inflation-protected cash flow from senior housing facilities. Occupancy rates recovering to pre-pandemic levels indicate strengthening demand. Sustainable 5.8% dividend yield supported by future earnings estimates. Recent pullback presents buying opportunity despite 25% run-up in past 12 months.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology